OxTalks Change Freeze Starts 2 March
Oxford Events, the new replacement for OxTalks, will launch on 16th March. The two-week OxTalks freeze period starts on Monday 2nd March. During this time, there will be no facility to publish or edit events. The existing OxTalks site will remain available to view during this period. Once Oxford Events launches, you will need a Halo login to submit events. Full details are available on the Staff Gateway.
Name: Professor Eric So
Head, Leukaemia and Stem Cell Biology Group, King’s College London
Events this person is speaking at:
Monday 25 April 2016
Targeting aberrant transcriptional and epigenetic networks for AML treatment
Date: 25 April 2016, 13:00 - 14:00
Speaker
:
Professor Eric So (Head, Leukaemia and Stem Cell Biology Group, King’s College London)
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Venue Details: Seminar Room
Organiser:
Anne Farmer (University of Oxford, NDM Experimental Medicine, RDM Investigative Medicine Division)
Host:
Professor Tom Milne (Weatherall Institute of Molecular Medicine, University of Oxford)
Targeting aberrant transcriptional and epigenetic networks for AML treatment
Date: 25 April 2016, 13:00 - 14:00
Speaker
:
Professor Eric So (Head, Leukaemia and Stem Cell Biology Group, King’s College London)
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Venue Details: Seminar Room
Organiser:
Linda Roberts (University of Oxford, Weatherall Institute of Molecular Medicine)
Host:
Professor Claus Nerlov (University of Oxford, Weatherall Institute of Molecular Medicine)
Tuesday 30 July 2024
Dissecting the crosstalk between epigenetic gene regulation and DNA damage responses in normal and malignant haematopoiesis
Date: 30 July 2024, 13:00 - 14:00
Speaker
:
Professor Eric So (Head, Leukaemia and Stem Cell Biology Group, King’s College London)
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Venue Details: Seminar Room
Organiser:
Beatriz Hirt-Font (University of Oxford, MRC Weatherall Institute of Molecular Medicine)
Host:
Ian Hsu (RDM, University of Oxford)
